Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
14.17
-0.59 (-4.00%)
At close: May 15, 2026, 4:00 PM EDT
14.17
0.00 (0.00%)
After-hours: May 15, 2026, 4:00 PM EDT
Biodesix Employees
Biodesix had 334 employees as of December 31, 2025. The number of employees increased by 61 or 22.34% compared to the previous year.
Employees
334
Change (1Y)
61
Growth (1Y)
22.34%
Revenue / Employee
$287,713
Profits / Employee
-$95,680
Market Cap
142.92M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 334 | 61 | 22.34% |
| Dec 31, 2024 | 273 | 56 | 25.81% |
| Dec 31, 2023 | 217 | -28 | -11.43% |
| Dec 31, 2022 | 245 | 27 | 12.39% |
| Dec 31, 2021 | 218 | 18 | 9.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| Fulgent Genetics | 1,315 |
| Castle Biosciences | 942 |
| Burning Rock Biotech | 667 |
| FONAR | 535 |
| MDxHealth | 364 |
| Prenetics Global | 285 |
| Exagen | 220 |
BDSX News
- 4 days ago - Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy - GlobeNewsWire
- 10 days ago - Biodesix price target raised to $22 from $20 at Canaccord - TheFly
- 10 days ago - Biodesix reports Q1 EPS (81c) vs. ($1.52) last year - TheFly
- 10 days ago - Biodesix Earnings Call Transcript: Q1 2026 - Transcripts
- 10 days ago - Biodesix raises FY26 revenue view to $108M-$114M from $106M-$112M - TheFly
- 11 days ago - Biodesix Announces First Quarter 2026 Results and Highlights - GlobeNewsWire
- 25 days ago - Eight option delistings on April 20th - TheFly
- 25 days ago - Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026 - GlobeNewsWire